An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye
George Ousler III,1 Douglas K Devries,2 Paul M Karpecki,3 Joseph B Ciolino41Ora, Inc, Andover, MA, USA; 2Eye Care Associates of Nevada, Sparks, NV, USA; 3Koffler Vision Group, Lexington, KY, USA; 4Massachusetts Eye and Ear, Boston, MA, USAAbstract: A single-center, open-label study consisting of tw...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/4db31c4f1c954fa3a7bda2b553b97236 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:4db31c4f1c954fa3a7bda2b553b97236 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:4db31c4f1c954fa3a7bda2b553b972362021-12-02T04:34:08ZAn evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye1177-5483https://doaj.org/article/4db31c4f1c954fa3a7bda2b553b972362015-02-01T00:00:00Zhttp://www.dovepress.com/an-evaluation-of-retainetrade-ophthalmic-emulsion-in-the-management-of-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483 George Ousler III,1 Douglas K Devries,2 Paul M Karpecki,3 Joseph B Ciolino41Ora, Inc, Andover, MA, USA; 2Eye Care Associates of Nevada, Sparks, NV, USA; 3Koffler Vision Group, Lexington, KY, USA; 4Massachusetts Eye and Ear, Boston, MA, USAAbstract: A single-center, open-label study consisting of two visits over the course of approximately 2 weeks was conducted to evaluate the efficacy of Retaine™ ophthalmic emulsion in improving the signs and symptoms of dry eye. Forty-two subjects were enrolled and received 1–2 drops twice daily of Retaine™ beginning at the first visit (day 1) and ending at the second visit. Subjects were instructed to complete a symptomatology diary twice daily prior to drop instillation through the morning of the second visit. Ocular sign and symptom assessments, visual acuity procedures, and comfort assessments were conducted during both visits. A statistically significant reduction was observed in mean breakup area on the second visit between the predose time and the postdose time (P=0.026). On the second visit, subjects had significantly less corneal fluorescein staining in the superior (P=0.002), central (P=0.017), corneal sum (P=0.011), and all ocular regions combined (P=0.038) than on the first visit. On the second visit, statistically significant reductions in dryness (P<0.001), grittiness (P=0.0217), ocular discomfort (P=0.0017), and all symptoms (P<0.001) were also seen as measured by the Ora Calibra™ Ocular Discomfort and 4-Symptom Questionnaire (0–5 scale). Subjects reported a statistically significant improvement in their abilities to work with a computer at night (P=0.044). Mean drop comfort scores ranged from 1.29–1.81 on the Ora Calibra™ 0–10 Drop Comfort Scale, on which 0 is very comfortable and 10 is very uncomfortable. Retaine™ demonstrates promising results as a novel artificial tear option for individuals suffering from dry eye. The unique mechanism of action of Retaine™ provides enhanced comfort and improves the quality of life of dry eye subjects while reducing the ocular signs of dry eye.Keywords: artificial tears, dry eye syndrome, quality of life, cationic, lipid emulsion, mean breakup areaOusler III GDevries DKKarpecki PMCiolino JBDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2015, Iss default, Pp 235-243 (2015) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Ophthalmology RE1-994 |
| spellingShingle |
Ophthalmology RE1-994 Ousler III G Devries DK Karpecki PM Ciolino JB An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye |
| description |
George Ousler III,1 Douglas K Devries,2 Paul M Karpecki,3 Joseph B Ciolino41Ora, Inc, Andover, MA, USA; 2Eye Care Associates of Nevada, Sparks, NV, USA; 3Koffler Vision Group, Lexington, KY, USA; 4Massachusetts Eye and Ear, Boston, MA, USAAbstract: A single-center, open-label study consisting of two visits over the course of approximately 2 weeks was conducted to evaluate the efficacy of Retaine™ ophthalmic emulsion in improving the signs and symptoms of dry eye. Forty-two subjects were enrolled and received 1–2 drops twice daily of Retaine™ beginning at the first visit (day 1) and ending at the second visit. Subjects were instructed to complete a symptomatology diary twice daily prior to drop instillation through the morning of the second visit. Ocular sign and symptom assessments, visual acuity procedures, and comfort assessments were conducted during both visits. A statistically significant reduction was observed in mean breakup area on the second visit between the predose time and the postdose time (P=0.026). On the second visit, subjects had significantly less corneal fluorescein staining in the superior (P=0.002), central (P=0.017), corneal sum (P=0.011), and all ocular regions combined (P=0.038) than on the first visit. On the second visit, statistically significant reductions in dryness (P<0.001), grittiness (P=0.0217), ocular discomfort (P=0.0017), and all symptoms (P<0.001) were also seen as measured by the Ora Calibra™ Ocular Discomfort and 4-Symptom Questionnaire (0–5 scale). Subjects reported a statistically significant improvement in their abilities to work with a computer at night (P=0.044). Mean drop comfort scores ranged from 1.29–1.81 on the Ora Calibra™ 0–10 Drop Comfort Scale, on which 0 is very comfortable and 10 is very uncomfortable. Retaine™ demonstrates promising results as a novel artificial tear option for individuals suffering from dry eye. The unique mechanism of action of Retaine™ provides enhanced comfort and improves the quality of life of dry eye subjects while reducing the ocular signs of dry eye.Keywords: artificial tears, dry eye syndrome, quality of life, cationic, lipid emulsion, mean breakup area |
| format |
article |
| author |
Ousler III G Devries DK Karpecki PM Ciolino JB |
| author_facet |
Ousler III G Devries DK Karpecki PM Ciolino JB |
| author_sort |
Ousler III G |
| title |
An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye |
| title_short |
An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye |
| title_full |
An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye |
| title_fullStr |
An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye |
| title_full_unstemmed |
An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye |
| title_sort |
evaluation of retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye |
| publisher |
Dove Medical Press |
| publishDate |
2015 |
| url |
https://doaj.org/article/4db31c4f1c954fa3a7bda2b553b97236 |
| work_keys_str_mv |
AT ousleriiig anevaluationofretainetradeophthalmicemulsioninthemanagementoftearfilmstabilityandocularsurfacestaininginpatientsdiagnosedwithdryeye AT devriesdk anevaluationofretainetradeophthalmicemulsioninthemanagementoftearfilmstabilityandocularsurfacestaininginpatientsdiagnosedwithdryeye AT karpeckipm anevaluationofretainetradeophthalmicemulsioninthemanagementoftearfilmstabilityandocularsurfacestaininginpatientsdiagnosedwithdryeye AT ciolinojb anevaluationofretainetradeophthalmicemulsioninthemanagementoftearfilmstabilityandocularsurfacestaininginpatientsdiagnosedwithdryeye AT ousleriiig evaluationofretainetradeophthalmicemulsioninthemanagementoftearfilmstabilityandocularsurfacestaininginpatientsdiagnosedwithdryeye AT devriesdk evaluationofretainetradeophthalmicemulsioninthemanagementoftearfilmstabilityandocularsurfacestaininginpatientsdiagnosedwithdryeye AT karpeckipm evaluationofretainetradeophthalmicemulsioninthemanagementoftearfilmstabilityandocularsurfacestaininginpatientsdiagnosedwithdryeye AT ciolinojb evaluationofretainetradeophthalmicemulsioninthemanagementoftearfilmstabilityandocularsurfacestaininginpatientsdiagnosedwithdryeye |
| _version_ |
1718401118383374336 |